(1995). 15-Deoxy-delta-12,14-prostaglandin J2 is ligand for the adipocyte determination factor PPARgamma. Cell
(1994). A and Williams JD. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-dcrived cytokines. Kidhey Int
(1986). A conserved AU sequence from the 3’-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell
(1995). A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell
(1991). A role for oxygen radicals second messengers.
(1996). A single amino acid difference between cyclooxygenase-1 (COX-l) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. JBiol Chem
(1996). A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity 322
(1987). A sulphonamido-indanone CGP 28237 (ZK 34228), novel non-steroidal anti-inflammatory agent without gastrointestinal ulcerogenicity in rats.
(1994). Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.
(1995). Aizawa A and Yamamoto S. Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of a selective COX-2 inhibitor. Adv Prostaglandin Thromboxane Leukotrienes Res
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase
(1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platclet aggregation. Nature
(1995). An examination of the source of the tyrosyl radical in ovine prostaglandin endoperoxide synthase-1. Biochem Biophys Res Commun
(1995). analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res
(1990). Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. JPharm Exp Therap
(1995). Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing carboxylic acid moiety.
(1995). Aspirin and the risk of colorectal cancer in women. New EnglJMed
(1995). Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.
(1994). Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to lq25 by fluorescence in situ hybridization. Genomics
(1995). Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins. J Bone Miner Res
(1994). Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85-kD cytosolic phospholipase A2.
(1996). binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.
(1995). Biological actions of delta-12-prostaglandin J2.
(1992). Biological activities and mechanisms of action of PGJ2 and related compounds; an update. Prostaglandins Leukotrienes Essential Fatty Acids
(1994). by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol Pharmacol
(1995). Characterisation of cyclooxygenase and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX-2. Biochim Biophys Acta
(1993). Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells.
(1994). Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene.
(1994). Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.
(1994). Characterization of the human gene (TBXAS1) encoding thromboxane synthase. EurJBiochem
(1994). Characterization of the tyrosyl radicals in ovine prostaglandin H synthase-1 by isotope replacement and site-directed mutagenesis.
(1993). Cloning two isoforms of rat cyclooxygenase; differential regulation of their expression. Arch Biochem Biophys
(1995). Coinduction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
(1995). Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages.
(1996). Control of arachidonate levels within inflammatory cells. Biochim Biophys Acta
(1994). Control of nitric oxide synthase expression by transforming growth factor-beta; implications for homeostasis. Prog Growth Factor Res
(1994). COX-1 and COX-2: toward the development of more selective NSAIDs. Drug News and Perspectives
(1994). Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1.
(1994). Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy.
(1995). Cyclo-oxygenase distribution in human placenta and decidua does not change with labour after term preterm delivery. Gynecol Obstet Invest
(1994). Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.
(1996). Cyclooxygenases-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane.
(1995). Cytokinemediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
(1994). Cytokines released by granulocytes and mononuclear cells stimulate amnion cell prostaglandin E2 production. Prostaglandins
(1992). Dexamethasone inhibits mitogen induction of the TISIO prostaglandin synthase cyclooxygenase gene.
(1995). Different intracellular locations for prostaglandin endoperoxide H synthase-1 and-2.
(1995). Differential activation of peroxisome proliferator-activated receptors by eicosanoids.
(1994). Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries.
(1995). Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog
(1995). Differential expression of thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line. Biochim Biophys Acta
(1994). Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.
(1995). Differentiation and growth on fibrin matrix modulate the cyclooxygenase expression and thromboxane production by cultured human placental trophoblasts. Prostaglandins Leukotrienes Essential Fatty Acids
(1995). Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.
(1992). eDNA cloning and functional activity of glucocorticoid-regulated inflammatory cyclooxygenase.
(1995). Effect of inhibitor time-dependency on selectivity towards cyclooxygcnase isoforms.
(1994). Effect of leflunomide on constitutive and inducible pathways of cellular eicosanoid generation. Agents Actions
(1995). Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. JRheumatol
(1994). Effects of lipopolysaccharide on human placental prostaglandin F2 alpha production in vitro. Prostaglandins Leukotrienes Essential Fatty Acids
(1995). Effects of oxidants and antioxidants on nuclear factor kB activation in three different cell lines: evidence against universal hypothesis involving oxygen radicals. Biochim Biophys Acta
(1993). Effects of transforming growth factor- and interleukin-l on expression of cyclooxygenase and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture.
(1995). EGF and TPA stimulate de novo synthesis of PGHS-1 and PGHS-2 through different signal transduction pathways. Prostaglandins Leukotrienes Essential Fatty Acids
(1995). Eicosanoids and the gastrointestinal tract. Gastroenterology
(1994). Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation.
(1994). Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through tyrosine kinase-signaling pathway in rat mesangial cells.
(1992). Enhanced release of prostaglandin E2 from macrophages of rats with silicosis.
(1993). Epidermal growth factor and transforming growth factor-alpha enhance the interleuMn-1 and tumor necrosis factor stimulated prostaglandin E2 production and the interleukin-1 specific binding on amnion cells. Prostaglandins Leukotrienes Essential Fatty Acids
(1994). Epidermal growth factor coordinately regulates the expression of prostaglandin G/H synthase and cytosolic phospholipase A2 genes in embryonic mouse cells.
(1995). Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.
(1995). Expression of cyclooxygenase types and 2 in human fetal membranes at term. AmJ Obstet Gynecol
(1995). Expression of messenger ribonucleic acid for epidermal growth factor (EGF), transforming growth factor (TGFalpha) and EGF receptor in human amnion cells; possible role of TGFalpha in prostaglandin E2 synthesis and cell proliferation.
(1995). Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res
(1995). Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase-2 in amnion cells. Endocrinology
(1996). Heme oxygenase: novel target for the modulation of the inflammatory response.
(1994). Herschman HR. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/ CRE transcription response element. Mol Cell Biol
(1994). How does NO activate hemeproteins?
(1982). How is the level of free arachidonic acid controlled in mammalian cells? BiochemJ
(1992). Human cyclooxygenase-2 cDNA.
(1996). Identification of cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene.
IgEdependent activation of cytokine-primed mouse cultured mast cells induces delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2.
(1995). IL-1 beta regulates rat mesangial cyclooxygenase II gene expression by tyrosine phosphorylation.
(1994). Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. BrJPharmacol
(1994). Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes.
(1994). Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids. Arth Rheumatism
(1994). Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.
(1995). Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. AmJ Respir Cell Mol Biol
(1994). Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cyclic AMP.
(1995). Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood
(1995). Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm Res
(1995). Inhibition of protein tyrosine phosphorylation in T cells by novel immunosuppressive agent, leflunomide.
(1993). Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide.
(1994). Interaction between peroxidase and cyclooxygenase activities in prostaglandin-endoperoxide synthase. Interpretation of reaction kinetics.
(1992). Interleukin 1 induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin
(1994). Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production.
(1994). Interleukin-1 activates preferentially cyclooxygenase rather than NO synthase pathway in human smooth muscle cells. Agents Actions
(1994). Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. Arth Rheumatism
(1995). Interleukin-1 beta-stimulated PGE2 production from early first trimester human decidual cells is inhibited by dexamethasone and progesterone. Prostaglandins
(1995). Interleukin-4 inhibits lipopolysaccharide-induced expression of prostaglandin H synthase-2 in human alveolar macrophages.
(1995). Interleukin-4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrowderived mast cells. Proc NatlAcad Sci USA
(1995). Interleukin-l induces cyclooxygenase-2 in cultured human decidual cells.
(1994). Interleukin-l-induced prostaglandin E2 biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A2 and cyclooxygenase-2. EurJBiochem
(1990). Interleukin4 (IL-4) inhibits secretion of IL-I, tumor necrosis factor- and IL-6 by human monocytes. Blood
(1994). Investigation of the role of cysteines in catalysis by prostaglandin endoperoxide synthase.
(1995). Involvement of protein kinase in delta-12-prostaglandin J2-induced expression of rat heme oxygenase-1 gene.
(1995). Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-c and lipopolysaccharide.
(1994). Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.
(1995). Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. BiochemJ
(1995). Leflunomide: an active anti-inflammatory and anti-proliferative agent in models of dermatologic disease. Inflamm Res
(1994). Ligand-induced prostaglandin synthesis requires expression of the TISIO/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages.
(1988). Lipocortin and the mechanism of action of the glucocorticoids.
(1994). Lipocortin-1; cellular mechanisms and clinical relevance.
(1994). Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function in vitro.
(1993). Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
(1994). Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.
(1995). Lipopolysaccharide induces time-dependent increases in prostaglandin H synthase-2- and cytosolic phospholipase A2 mRNA in cultured human microvessel-derived endothelial cells. Shock
(1985). Lung metabolism of eicosanoids.
(1995). Lutcinizing hormone induces prostaglandin endopcroxide synthase-2 and luteinization in vitro by A-kinase and Ckinase pathways. Endocrinology
(1994). Marumo E Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells.
(1994). Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
(1996). Mechanistic studies on the selective inhibition of cyclooxygenase-2 by indanone derivatives. Biochem Pharmacol
(1995). Meloxicam: influence on arachidonic acid metabolism; in vitro findings. Biochem Pharmacol
(1995). Modulation by nitric oxide of prostaglandin biosynthesis in the rat. BrJ Pharmacol
(1994). Molecular cloning and expression of human prostacyclin synthase.
(1995). Multiple second messenger pathways regulate IL-l-induced expression of PGHS-2 mRNA in normal human skin fibroblasts.
(1994). Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis.
(1993). Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. BrJPharmacol
(1993). Nimesulide; multifactorial therapeutic approach to the inflammatory process?; 7-year clinical experience. Drugs
(1995). Nimesulide: selectivity for cyclo-oxygenase 2 over cyclo-oxygenase 1. Inflamm Res
(1995). Nitric oxide enhances prostaglandin-h synthase-1 activity by berne-independent mechanism: evidence implicating nitrosothiols. JAm Chem Soc
(1994). Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats.
(1995). Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res
(1995). Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts.
(1993). NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects which causes minimal stomach lesions. General Pharmacology
(1994). NS398, new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins
(1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.
(1995). Pharmacology of selective cyclooxygenase-2 inhibitor, L-745,337: novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J Pharm Exp Therap
(1993). Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys
(1993). Phospholipase A2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. JImmunol
(1978). Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation and inhibition by anti-inflammatory steroids.
(1991). Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem
(1995). Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages.
(1995). Prostaglandin E2 release triggered by phagocytosis of latex particles. A distinct association with prostaglandin synthase isozymes in bone marrow macrophages. JImmunol
(1994). Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells.
Prostaglandin endoperoxide synthase-1 and synthase-2 expression in differentiating human monocytic cells. Agents Actions 1994; 41 (special conference issue):
(1992). Prostaglandin endoperoxide synthase. The aspirin acetylation region.
(1995). Prostaglandin endoperoxide synthases-1 and 2.
(1994). Prostaglandin endoperoxide synthases. Metal Ions
(1995). Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset.
(1994). Prostaglandin endoperoxideH synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor.
(1995). Prostaglandin G/H synthase-1 messenger RNA relative abundance in human amnion, choriodecidua and placenta before, during and after spontaneousonset labour at term. Gynecol Obstet Invest
(1995). Prostaglandin H synthase-l: evaluation of C-terminus function.
(1995). Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell
(1995). Prostaglandin synthase gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacininduced gastric ulceration. Cell
(1993). prostaglandins and loss of function. JLipidMediat Cell Signal
(1994). Prostaglandins in the treatment of cancer. Anticancer Drugs
(1994). Purification and characterization of recombinant human cyclooxygenase-2. Arch Biochem Biophys
(1995). Radicicol, protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis.
(1996). Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. BrJPharmacol
(1994). Recognition of endotoxin by cells leading to transmembrane signalling. Curt Opin Immunol
(1992). Regulation of cyclooxygenase and thromboxane synthase in human monocytes.
(1993). Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors. Biochem Pharmacol
(1994). Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.
(1994). Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines. JDent Res
(1994). Regulation of prostaglandin endoperoxide H synthase by glucocorticolds and activators of protein kinase C in the human amnion. JReprod Fertil
(1995). Regulation of prostaglandin production by nitric oxide; an in vivo analysis.
(1994). Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinology
(1995). Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937. Prostaglandins
(1995). Release of tumor necrosis factor- from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. JImmunol
(1995). Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature
(1994). Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet
(1994). Role of nitric oxide in PGF2-induced ocular hyperemia. Exp Eye Res
(1996). Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins
(1996). Role of Val59 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents.
(1994). Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors.
(1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide.
(1994). Selective inhibition of cyclooxygenase 2. Biochem Pharmacol
(1995). Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch Biochem Biophys
(1993). Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
(1994). Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells.
(1995). Staurosporine induces de novo synthesis of prostaglandin H synthase-2 in rat alveolar macrophages. Life Sciences
(1994). Stimulation of prostaglandin E2 production by interleukin-1 alpha and transforming growth factor alpha in osteoblastic MC3T3-E1 cells. JBone Miner Res
(1993). Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys
(1994). Structure of the human cyclo-oxygenase-2 gene. BiochemJ
(1992). Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is functional prostaglandin G/H synthase.
(1994). Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways. Biochim BiophysActa
(1993). Subcellular localization of prostaglandin endoperoxide
(1994). Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis.
(1995). Synthesis and biological evaluation of 2,3-diarylthiophenes selective
(1994). Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone.
(1995). T614, novel anti-rheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts. Jpn JPharmacol
(1994). TGF-beta inhibits both endotoxin-induced prostaglandin synthesis and expression of the TISlO/prostaglandin synthase 2 gene in murine macrophages.
(1994). The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells.
(1996). The immediate phase of c-kit ligand stimulation of mouse bone marrow derived mast cells elicits rapid 320
(1994). The isoforms of cyclooxygenase: structure and function.
(1994). The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum.
(1989). The pharmacological profile of CGP 28238, a highly potent anti-inflammatory compound. Agents Actions
(1995). The prostaglandin E1 analogue, Misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E,
(1994). The relative abundance of type to type 2 cyclo-oxygenase mRNA in human amnion at term.
(1995). The RXR heterodimers and orphan receptors. Cell
(1995). The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nature Structural Biology
(1994). The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature
(1975). Thromboxanes; a new group of biologically active compounds derived from prostaglandin endoperoxides.
(1995). Topology of prostaglandin H synthase-1 in the endoplasmic reticulum membrane. Arch Biochem Biophys
(1995). Transcription factors. Clin Exp Allergy
(1995). Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.
(1993). Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells.
(1995). Transcriptional roles of nuclear factor kB and nuclear factor-interleukin-6 in the tumor necrosis factor s-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. JBiol Chem
(1994). Transforming growth factor beta augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase gene both in Swiss 3T3 cells and in murine embryo fibroblasts.
(1995). Translational regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells.
(1993). Tyrosine kinase inhibitors suppress endotoxin and IL-lbeta-induced NO synthesis in aortic smooth muscle cells. AmJPhysiol
(1994). Uglik SE Mechanism of prostaglandin E2 release and increase in PGH2/PGE2 isomerase activity by PDGF: involvement of nitric oxide.
(1993). Worley PE Expression of mitogen-inducible cyclooxygenase in brain neurons; regulation by synaptic activity and glucocorticoids. Neuron
(1996). X-ray crystal structure of human cyclooxygenase-2.